Multidrug resistant tinea corporis/cruris: Response to voriconazole.
J Mycol Med
; 32(4): 101306, 2022 Nov.
Article
em En
| MEDLINE
| ID: mdl-35785725
ABSTRACT
The increasing worldwide resistance to terbinafine and older antifungal drugs, coupled with often erratic clinical responses to itraconazole, leaves dermatologists with limited options to deal with dermatophytic infections. Recalcitrant dermatophytoses has however, over past few years, become a significant public health issue, especially in India. In this context, we present a patient who failed four systemic antifungals sequentially and was subsequently cured with a 2 week course of voriconazole, an antifungal not routinely used for dermatophytoses as yet.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tinha
/
Tinea Cruris
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article